Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma

Michiie Sakamoto, Taisuke Mori, Yohei Masugi, Kathryn Effendi, Irie Rie, Wenlin Du

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. HCC occurs mainly in chronically diseased livers, e.g. following hepatitis B and C infection. These high-risk patients are closely followed up, and increasing numbers of small equivocal lesions are detected by imaging diagnosis. They are now widely recognized as precursor or early-stage HCCs and are classified as dysplastic nodule or early HCC. These lesions lack typical imaging and histology of ordinary HCC and do not show elevated serum markers of α-fetoprotein and PIVKA-II, for example. Molecular analysis of these lesions would help to develop molecular markers for objective histological diagnosis of early HCC and possibly new serum markers for early detection of HCC. It has been reported that HSP70, CAP2, glypican 3 and glutamine synthetase could serve as molecular markers for early HCC. Further analysis is expected to evaluate their usefulness in routine pathological diagnosis including biopsy diagnosis and also as serum markers for early detection of HCC.

Original languageEnglish
Pages (from-to)42-45
Number of pages4
JournalIntervirology
Volume51
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2008 Jun

Fingerprint

Hepatocellular Carcinoma
Biomarkers
Glypicans
Fetal Proteins
Glutamate-Ammonia Ligase
Hepatitis C
Hepatitis B
Liver Diseases
Histology
Biopsy
Infection
Neoplasms

Keywords

  • CAP2
  • Early hepatocellular carcinoma
  • Expression profile
  • HSP70
  • Molecular markers
  • Precancerous lesions

ASJC Scopus subject areas

  • Virology

Cite this

Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. / Sakamoto, Michiie; Mori, Taisuke; Masugi, Yohei; Effendi, Kathryn; Rie, Irie; Du, Wenlin.

In: Intervirology, Vol. 51, No. SUPPL. 1, 06.2008, p. 42-45.

Research output: Contribution to journalArticle

Sakamoto, Michiie ; Mori, Taisuke ; Masugi, Yohei ; Effendi, Kathryn ; Rie, Irie ; Du, Wenlin. / Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. In: Intervirology. 2008 ; Vol. 51, No. SUPPL. 1. pp. 42-45.
@article{d0096368b460426bb10802ac71032602,
title = "Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. HCC occurs mainly in chronically diseased livers, e.g. following hepatitis B and C infection. These high-risk patients are closely followed up, and increasing numbers of small equivocal lesions are detected by imaging diagnosis. They are now widely recognized as precursor or early-stage HCCs and are classified as dysplastic nodule or early HCC. These lesions lack typical imaging and histology of ordinary HCC and do not show elevated serum markers of α-fetoprotein and PIVKA-II, for example. Molecular analysis of these lesions would help to develop molecular markers for objective histological diagnosis of early HCC and possibly new serum markers for early detection of HCC. It has been reported that HSP70, CAP2, glypican 3 and glutamine synthetase could serve as molecular markers for early HCC. Further analysis is expected to evaluate their usefulness in routine pathological diagnosis including biopsy diagnosis and also as serum markers for early detection of HCC.",
keywords = "CAP2, Early hepatocellular carcinoma, Expression profile, HSP70, Molecular markers, Precancerous lesions",
author = "Michiie Sakamoto and Taisuke Mori and Yohei Masugi and Kathryn Effendi and Irie Rie and Wenlin Du",
year = "2008",
month = "6",
doi = "10.1159/000122603",
language = "English",
volume = "51",
pages = "42--45",
journal = "Intervirology",
issn = "0300-5526",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma

AU - Sakamoto, Michiie

AU - Mori, Taisuke

AU - Masugi, Yohei

AU - Effendi, Kathryn

AU - Rie, Irie

AU - Du, Wenlin

PY - 2008/6

Y1 - 2008/6

N2 - Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. HCC occurs mainly in chronically diseased livers, e.g. following hepatitis B and C infection. These high-risk patients are closely followed up, and increasing numbers of small equivocal lesions are detected by imaging diagnosis. They are now widely recognized as precursor or early-stage HCCs and are classified as dysplastic nodule or early HCC. These lesions lack typical imaging and histology of ordinary HCC and do not show elevated serum markers of α-fetoprotein and PIVKA-II, for example. Molecular analysis of these lesions would help to develop molecular markers for objective histological diagnosis of early HCC and possibly new serum markers for early detection of HCC. It has been reported that HSP70, CAP2, glypican 3 and glutamine synthetase could serve as molecular markers for early HCC. Further analysis is expected to evaluate their usefulness in routine pathological diagnosis including biopsy diagnosis and also as serum markers for early detection of HCC.

AB - Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. HCC occurs mainly in chronically diseased livers, e.g. following hepatitis B and C infection. These high-risk patients are closely followed up, and increasing numbers of small equivocal lesions are detected by imaging diagnosis. They are now widely recognized as precursor or early-stage HCCs and are classified as dysplastic nodule or early HCC. These lesions lack typical imaging and histology of ordinary HCC and do not show elevated serum markers of α-fetoprotein and PIVKA-II, for example. Molecular analysis of these lesions would help to develop molecular markers for objective histological diagnosis of early HCC and possibly new serum markers for early detection of HCC. It has been reported that HSP70, CAP2, glypican 3 and glutamine synthetase could serve as molecular markers for early HCC. Further analysis is expected to evaluate their usefulness in routine pathological diagnosis including biopsy diagnosis and also as serum markers for early detection of HCC.

KW - CAP2

KW - Early hepatocellular carcinoma

KW - Expression profile

KW - HSP70

KW - Molecular markers

KW - Precancerous lesions

UR - http://www.scopus.com/inward/record.url?scp=44949120637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949120637&partnerID=8YFLogxK

U2 - 10.1159/000122603

DO - 10.1159/000122603

M3 - Article

C2 - 18544947

AN - SCOPUS:44949120637

VL - 51

SP - 42

EP - 45

JO - Intervirology

JF - Intervirology

SN - 0300-5526

IS - SUPPL. 1

ER -